A Study to Assess the Safety and Efficacy of Oral Insulin in T2DM Patients With Nonalcoholic Steatohepatitis (NASH)

NCT04618744 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2
NASH - Nonalcoholic Steatohepatitis

Interventions

DRUG: ORMD-0801 (Insulin) capsule 8 mg BD
OTHER: Placebo

Sponsor

Oramed, Ltd.

Collaborators

[object Object]